Glia maturation factor-γ regulates amyloid-β42 phagocytosis through scavenger receptor class A type I in murine

Wulin Aerbajinai1, Jianqiong Zhu1, Kyung Chin1

  • 1Molecular and Clinical Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, BG 10, RM 9N113, 10 Center Dr., Bethesda, MD 20892, United States.

Insights

Glia maturation factor-gamma (GMFG) regulates macrophage clearance of amyloid-beta (Aβ) by controlling scavenger receptor expression. Reducing GMFG enhances Aβ uptake, offering potential Alzheimer

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Dysfunctional amyloid-beta (Aβ) clearance by immune cells is linked to Alzheimer's disease (AD).
  • The precise mechanisms behind impaired Aβ phagocytosis in macrophages remain unclear.
  • Glia maturation factor-gamma (GMFG), an actin-disassembly protein, is highly expressed in immune cells.

Purpose of the Study:

  • To investigate the role of GMFG in macrophage phagocytosis of Aβ.
  • To determine GMFG's influence on type I class A scavenger receptor expression and function.
  • To elucidate the molecular pathways involving GMFG in Aβ clearance.

Main Methods:

  • GMFG knockdown and overexpression in bone marrow-derived macrophages and RAW264.7 cells.
  • Assessment of Aβ42 uptake via phagocytosis assays.
  • Analysis of type I class A scavenger receptor expression, ubiquitination, and phosphorylation.
  • Investigation of downstream signaling pathways including MafB and RanBP2 interactions.

Main Results:

  • GMFG knockdown significantly increased macrophage Aβ42 phagocytosis, while overexpression reduced it.
  • GMFG knockdown enhanced type I class A scavenger receptor expression and Aβ uptake, confirmed by antibody blocking.
  • GMFG modulated Aβ42-induced ubiquitination and phosphorylation of the scavenger receptor, involving MafB and RanBP2.

Conclusions:

  • GMFG acts as a novel negative regulator of type I class A scavenger receptor-mediated Aβ phagocytosis in macrophages.
  • Understanding GMFG's role provides insights into potential therapeutic strategies for Alzheimer's disease.
  • Targeting GMFG may enhance immune cell clearance of Aβ, potentially slowing AD progression.

Related Concept Videos